Helmut Hörn

Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data

B. Wieseler, M. F. Kerekes, Petra Kohlepp, 2020, BMJ.

Early benefit assessment of new drugs in Germany - results from 2011 to 2012.

B. Wieseler, N. Mcgauran, Helmut Hörn, 2014, Health policy.

Information on new drugs at market entry: retrospective analysis of health technology assessment reports versus regulatory reports, journal publications, and registry reports

H. Kölsch, U. Grouven, B. Wieseler, 2015, BMJ : British Medical Journal.